Affymax Announces Upcoming Webcasts and Conference Participation

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced the company’s participation in the following investors conferences.

• 24^th Annual Piper Jaffray Health Care Conference
  Tuesday, November 27, 2012 in New York City
  10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)
• 2012 Deutsche Bank dbAccess BioFEST
  Monday, December 3, 2012 in Boston
  2:15 p.m. Eastern Time (11:15 a.m. Pacific Time)

A live webcast of the presentations will be available on the investors section of the Company's website at http://www.investors.affymax.com/events.cfm. A replay will also be available for 30 days following the presentations.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.

The company's first marketed product, OMONTYS^® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. For additional information, please visit www.affymax.com.